Leaflet AIRONYL 1.5mg / 5ml syrup
Indicated for: asthma; chronic obstructive pulmonary disease
Route of administration: oral
Substance: terbutaline (beta-2 adrenergic agonist)
ATC: R03CC03 (Respiratory system | Adrenergics for systemic use | Selective beta-2-adrenoreceptor agonists)
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
Terbutaline is a beta-2 adrenergic agonist used for the treatment of bronchial asthma, chronic obstructive bronchitis, and other respiratory conditions involving bronchospasm. It works by relaxing the smooth muscles of the airways, making breathing easier.
The medication is available in the form of tablets, inhalation solutions, or injections and should be used as directed by a doctor. The dosage and frequency of administration are adjusted based on the severity of symptoms.
Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms or the use of other medications.
Common side effects include tremors, palpitations, nervousness, and headaches. In rare cases, severe reactions such as cardiac arrhythmias or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about AIRONYL 1.5mg / 5ml
- Substance: terbutaline
- Date of latest medicines list: 01-07-2013
- Product code: W51654001
- Concentration: 1.5mg / 5ml
- Pharmaceutical form: syrup
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for terbutaline
Concentrations available for terbutaline
- 0.5mg/ml
- 1.5mg/5ml